Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6099906 | Journal of Crohn's and Colitis | 2012 | 7 Pages |
Abstract
Higher levels of IL-17A, IL-23, and IL-12 at baseline may be predictive markers for poor therapeutic response to maintenance infliximab therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Kotaro Ogawa, Takayuki Matsumoto, Motohiro Esaki, Takehiro Torisu, Mitsuo Iida,